Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin
Overview
Affiliations
While oral isotretinoin is renowned for its ability to treat acne vulgaris, many of its off-label uses continue to go underappreciated. Since the last review on the unapproved indications of isotretinoin, relevant publications have surfaced with new recommendations. This article attempts to provide physicians with the latest information regarding successful and unsuccessful use of isotretinoin as an effective treatment for dermatological conditions, such as rosacea, psoriasis, pityriasis rubra pilaris, condyloma acuminatum, granuloma annulare, Darier's disease, systemic cutaneous lupus erythematosus, nonmelanoma skin cancer, and hidradenitis suppurativa. Variations in dosage regimens and isotretinoin viability as an alternative to other standard treatments are also discussed in relation to these conditions.
Practices, Efficacy, and Reported Side Effects Associated with Isotretinoin Treatment in Palestine.
Abukhalil A, Yousef M, Ammar M, Jaghama W, Al-Shami N, Naseef H Patient Prefer Adherence. 2024; 18:487-501.
PMID: 38414983 PMC: 10898599. DOI: 10.2147/PPA.S442436.
Besekar S, Jogdand S, Naqvi W Cureus. 2023; 15(6):e40296.
PMID: 37448439 PMC: 10337497. DOI: 10.7759/cureus.40296.
Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?.
Vassileva S, Mateeva V, Drenovska K Clin Dermatol. 2021; 39(3):430-445.
PMID: 34518001 PMC: 7959882. DOI: 10.1016/j.clindermatol.2021.01.020.
Consensus on the therapeutic management of rosacea - Brazilian Society of Dermatology.
de Oliveira C, Almeida L, Bonamigo R, Lima C, Bagatin E An Bras Dermatol. 2020; 95 Suppl 1:53-69.
PMID: 33172727 PMC: 7772594. DOI: 10.1016/j.abd.2020.08.001.
Chu S, Michelle L, Ekelem C, Sung C, Rojek N, Mesinkovska N Arch Dermatol Res. 2020; 313(6):391-430.
PMID: 33151346 DOI: 10.1007/s00403-020-02152-4.